Resonance Health Limited Stock: price and insider trades · Australia
Resonance Health Limited: what insiders have been doing
This page follows insider dealings at Resonance Health Limited as filed with ASX. In the past year (18 October 2025 to 18 October 2026), 5 filings came from 2 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
No insider has bought Resonance Health Limited shares on the open market in the past twelve months.
Compared with its exchange (1,605 companies, median 4 filings), a count of 5 filings is above the norm.
These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended June 2024 · cache
- ●Executives0ASX
- ●Executives73,837 AUD0ASX
- ●Executives3,963 AUD0ASX
- ●Unknown0ASXShareASXASX:2924-03082967-6A1322296
- ●Unknown0ASXShareASXASX:2924-03082963-6A1322295
5 of 5 declarations
About Resonance Health Limited
Resonance Health Limited is a company listed on the XASX market, specializing in the development of innovative health solutions. It focuses on improving medical diagnostics and treatments.